Concomitant Tarceva and Irradiation in Patients in Local-Regionally Advanced Non-Small Cell Lung Cancer. A Phase II Study.
Phase of Trial: Phase II
Latest Information Update: 10 May 2017
At a glance
- Drugs Erlotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms TARLAL
- 19 May 2016 Status changed from recruiting to completed.
- 14 Nov 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 24 Apr 2009 New trial record